15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering Repligen Corporation, 11 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $135.00 to $208.00, a moderate spread. The average target of $166.38 sits 1% below the current $167.55. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.58 next quarter toward $2.64 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Strong Buy
Strong Buy00%
Buy1185%
Hold215%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to Repligen Corporation.
As of Sep, 11 of 12 firms rate RGEN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
RGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.58
Range $0.56 – $0.61 · 17 analysts · +18% YoY
Next period, 17 analysts expect Repligen Corporation to earn $0.58 a share (range $0.56 – $0.61), versus $0.49 a year earlier. Full-year consensus is $2.06, growing to $2.64 the year after.
REVENUE · NEXT QUARTER
$222.0M
Range $215.0M – $251.0M · 17 analysts · +12% YoY
Revenue is expected to reach $222.0M (range $215.0M – $251.0M), +12.2% year-over-year. Full-year consensus is $827.0M, rising to $968.6M next year.
Top analysts covering Repligen Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RGEN.
#1
Conor McNamara
RBC Capital · Rank #201
Buy
$204.00+21.8% to target
Overall win rate
34%
+ Follow
#2
Luke Sergott
Barclays · Rank #246
Buy
$175.00+4.4% to target
Overall win rate
40%
+ Follow
#3
KM
Kyle Mikson
Canaccord Genuity · Rank #263
Hold
$145.00-13.5% to target
Overall win rate
34%
+ Follow
#4
Raghuram Selvaraju
HC Wainwright & Co. · Rank #312
Buy
$208.00+24.1% to target
Overall win rate
36%
+ Follow
#5
RW
Robert Wasserman
Benchmark · Rank #336
Buy
$185.00+10.4% to target
Overall win rate
39%
+ Follow
RGEN stock forecast FAQ
What is RGEN's average 12-month price target?+
The 13 analysts with a live target average $166.38 for Repligen Corporation over the next 12 months, ranging from a $208.00 high to a $135.00 low.
Is RGEN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 13 analyst ratings, 11 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for RGEN?+
The Street-high target is $208.00 (HC Wainwright & Co.), and the Street-low is $135.00 (Jefferies). The average of all 13 active targets is $166.38.
How many Wall Street analysts cover RGEN?+
13 analysts have an active rating on Repligen Corporation, and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering RGEN?+
Among analysts who currently cover RGEN, Conor McNamara of RBC Capital has the strongest overall Quantellect track record (Rank #201). Their current call is Buy with a $204.00 target.
What is Repligen Corporation's projected EPS for next quarter?+
The consensus estimate is $0.58 per share (range $0.56 – $0.61) across 17 analysts. Full-year EPS is projected at $2.06, rising to $2.64 the following year.
How much revenue is Repligen Corporation expected to report next quarter?+
Consensus revenue is $222.0M (range $215.0M – $251.0M). Full-year revenue is projected at $827.0M, growing to $968.6M next year.
Have analysts been upgrading or downgrading RGEN lately?+
As of Sep, 11 of 12 firms rate RGEN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Wells Fargo
